U.S. markets closed
  • S&P 500

    4,577.10
    +64.06 (+1.42%)
     
  • Dow 30

    34,639.79
    +617.75 (+1.82%)
     
  • Nasdaq

    15,381.32
    +127.27 (+0.83%)
     
  • Russell 2000

    2,206.33
    +58.91 (+2.74%)
     
  • Crude Oil

    67.34
    +0.84 (+1.26%)
     
  • Gold

    1,770.00
    +7.30 (+0.41%)
     
  • Silver

    22.40
    +0.08 (+0.35%)
     
  • EUR/USD

    1.1307
    -0.0015 (-0.14%)
     
  • 10-Yr Bond

    1.4480
    +0.0140 (+0.98%)
     
  • GBP/USD

    1.3296
    +0.0019 (+0.14%)
     
  • USD/JPY

    113.0540
    -0.1550 (-0.14%)
     
  • BTC-USD

    56,550.32
    -548.82 (-0.96%)
     
  • CMC Crypto 200

    1,450.10
    +11.22 (+0.78%)
     
  • FTSE 100

    7,129.21
    -39.47 (-0.55%)
     
  • Nikkei 225

    27,753.37
    0.00 (0.00%)
     

Pacific Biosciences of California, Inc. Third Quarter 2021 Financial Results Call

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

MENLO PARK, Calif., Oct. 19, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) will hold its quarterly conference call to discuss its third quarter 2021 financial results on Tuesday, November 2, 2021, at 4:30pm Eastern Time.

The call will be webcast and may be accessed at Pacific Biosciences’ website at: https://investor.pacificbiosciences.com/.

Date: Tuesday, November 2, 2021

Time: 4:30pm ET

Listen via Internet: https://investor.pacificbiosciences.com/

Toll-free: 888.366.7247

International: 707.287.9330

Conference ID: 5129207

Replay: https://investor.pacificbiosciences.com

About Pacific Biosciences

Pacific Biosciences of California, Inc. (NASDAQ: PACB) is empowering life scientists with highly accurate long-read sequencing. The company’s innovative instruments are based on Single Molecule, Real-Time (SMRT®) Sequencing technology, which delivers a comprehensive view of genomes, transcriptomes, and epigenomes, enabling access to the full spectrum of genetic variation in any organism. Cited in thousands of peer-reviewed publications, PacBio® sequencing systems are in use by scientists around the world to drive discovery in human biomedical research, plant and animal sciences, and microbiology.

Contacts

Investors:
Todd Friedman
650.521.8450
ir@pacificbiosciences.com